Cipher Pharmaceuticals Inc (CPH) — Capital Reinvestment Ratio

Latest as of March 2026: 0.00x

Cipher Pharmaceuticals Inc (CPH) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow (CA$4.45 Million) in capital expenditures (CA$984.00). See Cipher Pharmaceuticals Inc (CPH) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

CA$4.45 Million
CAD

Capital Expenditures

CA$984.00
CAD

Data as of

Mar 2026
Most recent filing

Cipher Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2025)

This chart tracks Cipher Pharmaceuticals Inc's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for Cipher Pharmaceuticals Inc (2010–2025)

Year-by-year Capital Reinvestment Ratio for Cipher Pharmaceuticals Inc from 2010 to 2025. For live market cap and broader valuation context, see market cap of Cipher Pharmaceuticals Inc.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2025 0.00x CA$30.25 Million CA$28.49K ▼ -58.2%
2024 0.00x CA$19.55 Million CA$44.00K ▼ -75.0%
2023 0.01x CA$16.00 Million CA$144.00K ▲ +17.5%
2022 0.01x CA$10.57 Million CA$81.00K ▲ +30.6%
2021 0.01x CA$13.81 Million CA$81.00K ▼ -91.0%
2020 0.07x CA$11.69 Million CA$760.00K ▼ -56.1%
2019 0.15x CA$8.86 Million CA$1.31 Million ▼ -74.8%
2018 0.59x CA$11.28 Million CA$6.63 Million ▲ +5695.3%
2017 0.01x CA$19.93 Million CA$202.00K ▼ -81.6%
2016 0.06x CA$11.47 Million CA$632.00K ▼ -94.3%
2015 0.97x CA$7.76 Million CA$7.57 Million ▲ +48456.0%
2013 0.00x CA$7.02 Million CA$14.09K ▼ -98.3%
2012 0.12x CA$6.90 Million CA$795.11K ▼ -80.5%
2010 0.59x CA$1.24 Million CA$735.88K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow